Table of contents
Narcolepsy
What's new
Updated 2023 BTS, 2021 AASM, and 2021 EAN guidelines for the diagnosis and management of narcolepsy in pediatric patients.
Guidelines
Key sources
The following summarized guidelines for the management of narcolepsy are prepared by our editorial team based on guidelines from the British Thoracic Society (BTS 2023), the American Academy of Sleep Medicine (AASM 2021), and the European Academy of Neurology (EAN 2021).
1
2
3
Medical management
Management of excessive daytime sleepiness
As per AASM 2021 guidelines:
Offer the following medications for the treatment of excessive daytime sleepiness in adult patients with narcolepsy:
modafinil
pitolisant
sodium oxybate
solriamfetol
A
Consider offering the following medications for the treatment of excessive daytime sleepiness in adult patients with narcolepsy:
armodafinil
dextroamphetamine
methylphenidate
C
More topics in this section
Management of cataplexy
Management of disturbed nighttime sleep
Management of sleep paralysis and sleep-related hallucinations
Agents with no evidence for benefit
Nonpharmacologic interventions
Therapeutic procedures
Specific circumstances
Pediatric patients, evaluation: as per BTS 2023 guidelines, suspect other diagnoses, including narcolepsy, with possible coexistent cataplexy, sleep paralysis, hypnagogic and hypnopompic hallucinations, and circadian rhythm disorders, in pediatric patients with persisting excessive daytime sleepiness despite exclusion or effective treatment of sleep-disordered breathing.
B
Show 3 more
More topics in this section
Pediatric patients (management)
Patients with other sleep disorders